Literature DB >> 15948928

Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?

N S Baber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15948928      PMCID： PMC1884861          DOI： 10.1111/j.1365-2125.2005.02427.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

Review 1.  Dose estimation for children.

Authors:  Nigel Baber; Deborah Pritchard
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  Pharmacogenetics--expectations and reality.

Authors:  Geoff Tucker
Journal:  BMJ       Date:  2004-07-03
  2 in total
  4 in total

1.  Testing new drugs in naked apes and getting the dose right in their young.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

Review 2.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  The EU-regulation on medicinal products for paediatric use: impacts on child and adolescent psychiatry and clinical research with minors.

Authors:  Michael Kölch; Kathlen Schnoor; Jörg M Fegert
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-04-07       Impact factor: 4.785

4.  The ethics of psychopharmacological research in legal minors.

Authors:  Jacinta Oa Tan; Michael Koelch
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-12-08       Impact factor: 3.033
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.